Alimentary Pharmacology & Therapeutics | 2021
Systematic review: hepatitis C viraemic allografts to hepatitis C‐negative recipients in solid organ transplantation
Abstract
Given the success of direct‐acting antivirals (DAAs) in treating hepatitis C (HCV), interest is growing in utilizing solid organs from allografts with active HCV to expand donor availability.